Showing 99,401 - 99,420 results of 112,327 for search '(( 12 we decrease ) OR ( 5 ((((ng decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.52s Refine Results
  1. 99401

    JuliaCon2018 DataDeps.jl.pdf by Lyndon White (5615612)

    Published 2018
    “…</li><li><a href="https://github.com/oxinabox/InternedStrings.jl" rel="nofollow me noopener noreferrer" target="_blank">InternedStrings.jl</a> For decreasing memory usage, and speeding up equality checks.…”
  2. 99402

    Table_1_Maternal Conjugated Linoleic Acid Supply in Combination With or Without Essential Fatty Acids During Late Pregnancy and Early Lactation: Investigations on Physico-Chemical... by Wendy Liermann (9774182)

    Published 2022
    “…The current preliminary study investigated effects of a maternal fatty acid supplementation (MFAS) during transition period with coconut oil (CON, control), CLA (Lutalin®), or CLA + EFA (Lutalin® + essential fatty acids–linseed oil; safflower oil) on physico-chemical characteristics of jejunal content and microbiota of 5-day-old calves. …”
  3. 99403

    Regulation of BRCA1 by Cezanne is cell-cycle dependent. by Longqiang Wang (110603)

    Published 2025
    “…<p><b>(A)</b> Cezanne knockdown leads to decreased BRCA1 protein level in cells synchronized in G1 and S phase of the cell cycle. …”
  4. 99404

    MAPK signaling is elevated in <i>Socs36E</i> mutant clones. by Marc Amoyel (848355)

    Published 2016
    “…The hub is outlined by a dotted line. Scale bar = 5 μM.</p>…”
  5. 99405

    Datasets and metadata supporting the published article: BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression by Hanan S. Elsarraj (8473172)

    Published 2020
    “…</div><div> </div><div><b><br></b></div><div><b>Study aims and methodology: </b></div><div>The aim of the related study was to determine the molecular processes underlying progression to invasion in DCIS using PDX DCIS MIND animal models. Using a novel intraductal model they identify downregulation of specific STAT3 targets to promote progression and use a purified component from rosemary extract to show that treatment <i>in vivo</i> decreases DCIS progression in patient derived DCIS and cell line models.…”
  6. 99406

    H3K27me3 spreading is affected in the <i>lhp1</i> and <i>clf</i> mutants. by Alaguraj Veluchamy (3154434)

    Published 2016
    “…<p><b>(A)</b> Venn diagram showing differential marking of H3K27me3 deposition and LHP1 binding. …”
  7. 99407

    Table_1_Pharmacokinetic and Pharmacogenetic Factors Contributing to Platelet Function Recovery After Single Dose of Ticagrelor in Healthy Subjects.DOCX by Qian Zhu (191342)

    Published 2019
    “…Effects of CYP2C19<sup>*</sup>2, CYP2C19<sup>*</sup>3, CYP3A5<sup>*</sup>3, UGT1A1<sup>*</sup>6, UGT1A1<sup>*</sup>28, UGT2B7<sup>*</sup>2, UGT2B7<sup>*</sup>3, SLCO1B1 388A>G, and SLCO1B1 521T>C, on the pharmacokinetics of ticagrelor and M8, and platelet function recovery were investigated.…”
  8. 99408

    HIV specific CD4+ and CD8+ T cell functionality is reduced in HIV infected individuals co-infected with latent Mycobacterium tuberculosis infection (LTBI) and active Tuberculosis (... by Shivan Chetty (159334)

    Published 2015
    “…<b>(E)</b> HIV-specific four function CD4+ T cells were not present in subjects co-infected with LTBI <b>(F)</b> Further decreases in HIV-specific CD4+ T cell polyfunctionality were observed in HIV positive subjects co-infected with TB, being replaced by a largely mono-functional profile with a decreased amount of triple cytokine cells (5% as compared to 13% in HIV/LTBI and 15% in HIV mono-infection). …”
  9. 99409

    Table_1_Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systema... by Sukrit Treewaree (14577911)

    Published 2023
    “…</p>Results<p>Sixteen studies (9 recent RCTs) were included, and a total of 16,710 HFmrEF or HFpEF patients were enrolled. …”
  10. 99410

    Image_1_Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systema... by Sukrit Treewaree (14577911)

    Published 2023
    “…</p>Results<p>Sixteen studies (9 recent RCTs) were included, and a total of 16,710 HFmrEF or HFpEF patients were enrolled. …”
  11. 99411

    Data_Sheet_1_Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated sy... by Sukrit Treewaree (14577911)

    Published 2023
    “…</p>Results<p>Sixteen studies (9 recent RCTs) were included, and a total of 16,710 HFmrEF or HFpEF patients were enrolled. …”
  12. 99412

    DataSheet_1_Postoperative Long-Term Independence Among the Elderly With Meningiomas: Function Evolution, Determinant Identification, and Prediction Model Development.docx by Haoyi Li (593226)

    Published 2021
    “…Independent risk factors for postoperative long-term non-independence included: advanced age (70–74 vs. 65–69 OR: 2.631; 95% CI: 1.545–4.481 and ≥75 vs. 65–69 OR: 3.833; 95% CI: 1.667–8.812), recurrent meningioma (OR: 7.791; 95% CI: 3.202–18.954), location in the skull base (OR: 2.683; 95% CI: 1.383–5.205), tumor maximal diameter >6 cm (OR: 3.089; 95% CI: 1.471–6.488), nerves involved (OR: 3.144; 95% CI: 1.585–6.235), high risk of WHO grade and biological behavior (OR: 2.294; 95% CI: 1.193–4.408), recurrence during follow-up (OR: 10.296; 95% CI: 3.253–32.585), lower preoperative KPS (OR: 0.964; 95% CI: 0.938–0.991) and decreased KPS on discharge (OR: 0.967; 95% CI: 0.951–0.984) (P < 0.05). …”
  13. 99413

    Image_2_Postoperative Long-Term Independence Among the Elderly With Meningiomas: Function Evolution, Determinant Identification, and Prediction Model Development.tif by Haoyi Li (593226)

    Published 2021
    “…Independent risk factors for postoperative long-term non-independence included: advanced age (70–74 vs. 65–69 OR: 2.631; 95% CI: 1.545–4.481 and ≥75 vs. 65–69 OR: 3.833; 95% CI: 1.667–8.812), recurrent meningioma (OR: 7.791; 95% CI: 3.202–18.954), location in the skull base (OR: 2.683; 95% CI: 1.383–5.205), tumor maximal diameter >6 cm (OR: 3.089; 95% CI: 1.471–6.488), nerves involved (OR: 3.144; 95% CI: 1.585–6.235), high risk of WHO grade and biological behavior (OR: 2.294; 95% CI: 1.193–4.408), recurrence during follow-up (OR: 10.296; 95% CI: 3.253–32.585), lower preoperative KPS (OR: 0.964; 95% CI: 0.938–0.991) and decreased KPS on discharge (OR: 0.967; 95% CI: 0.951–0.984) (P < 0.05). …”
  14. 99414

    Image_1_Postoperative Long-Term Independence Among the Elderly With Meningiomas: Function Evolution, Determinant Identification, and Prediction Model Development.tif by Haoyi Li (593226)

    Published 2021
    “…Independent risk factors for postoperative long-term non-independence included: advanced age (70–74 vs. 65–69 OR: 2.631; 95% CI: 1.545–4.481 and ≥75 vs. 65–69 OR: 3.833; 95% CI: 1.667–8.812), recurrent meningioma (OR: 7.791; 95% CI: 3.202–18.954), location in the skull base (OR: 2.683; 95% CI: 1.383–5.205), tumor maximal diameter >6 cm (OR: 3.089; 95% CI: 1.471–6.488), nerves involved (OR: 3.144; 95% CI: 1.585–6.235), high risk of WHO grade and biological behavior (OR: 2.294; 95% CI: 1.193–4.408), recurrence during follow-up (OR: 10.296; 95% CI: 3.253–32.585), lower preoperative KPS (OR: 0.964; 95% CI: 0.938–0.991) and decreased KPS on discharge (OR: 0.967; 95% CI: 0.951–0.984) (P < 0.05). …”
  15. 99415

    Image1_Paleoclimate Records of the Middle Okinawa Trough Since the Middle Holocene: Modulation of the Low-Latitude Climate.jpg by Lei Liu (5074)

    Published 2022
    “…In contrast, RI-OH temperatures varied from 17.4 to 26.0°C, showing a lower trend than TEX<sup>H</sup><sub>86</sub> SSTs. …”
  16. 99416

    Presentation_1_Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy.pptx by Wei Huang (36889)

    Published 2021
    “…</p>Results<p>The radiation dose to PBM (V<sub>5</sub>~V<sub>45</sub>, D<sub>mean</sub>, P<0.05), PBM sub-regions (V<sub>10</sub>~V<sub>35</sub>, D<sub>mean</sub>, P<0.05) and both femoral heads (V<sub>5</sub>~V<sub>40</sub>, D<sub>mean</sub>, P<0.05) decreased significantly in the PBM sparing IMRT group compared with that of the non-PBM sparing IMRT group (P<0.05). …”
  17. 99417

    Image_3_Postoperative Long-Term Independence Among the Elderly With Meningiomas: Function Evolution, Determinant Identification, and Prediction Model Development.tif by Haoyi Li (593226)

    Published 2021
    “…Independent risk factors for postoperative long-term non-independence included: advanced age (70–74 vs. 65–69 OR: 2.631; 95% CI: 1.545–4.481 and ≥75 vs. 65–69 OR: 3.833; 95% CI: 1.667–8.812), recurrent meningioma (OR: 7.791; 95% CI: 3.202–18.954), location in the skull base (OR: 2.683; 95% CI: 1.383–5.205), tumor maximal diameter >6 cm (OR: 3.089; 95% CI: 1.471–6.488), nerves involved (OR: 3.144; 95% CI: 1.585–6.235), high risk of WHO grade and biological behavior (OR: 2.294; 95% CI: 1.193–4.408), recurrence during follow-up (OR: 10.296; 95% CI: 3.253–32.585), lower preoperative KPS (OR: 0.964; 95% CI: 0.938–0.991) and decreased KPS on discharge (OR: 0.967; 95% CI: 0.951–0.984) (P < 0.05). …”
  18. 99418

    Data_Sheet_1_Anti-hyperuricemic and Anti-inflammatory Effects of Marantodes pumilum as Potential Treatment for Gout.docx by Eldiza Puji Rahmi (8584506)

    Published 2020
    “…The anti-hyperuricemic activity was initially assessed by XO inhibition with a spectrophotometric in vitro assay. The most active extract was further investigated on hyperuricemic rat model induced by potassium oxonate to determine serum uric acid levels and liver XO effect. …”
  19. 99419
  20. 99420

    DataSheet_1_Including Volume Effects in Biological Treatment Plan Optimization for Carbon Ion Therapy: Generalized Equivalent Uniform Dose-Based Objective in TRiP98.pdf by Marco Battestini (12268814)

    Published 2022
    “…In particular, for a plan containing multiple OARs, we obtained the same target coverage and similar DVHs for OARs with a small volume effect while decreasing the mean dose received by the proximal parotid, thus reducing its NTCP by a factor of 2.5. …”